Summary of Purpose
To study the safety and efficacy of endovascular treatment in MR or CT perfusion-selected patients suffering acute ischemic stroke due to a proximal large vessel anterior circulation occlusion (e.g. ICA and/or MCA-M1 segment) who present “beyond the typical therapeutic window” defined as “last time seen well” greater than 8 hours. As such, this time frame applies to both witnessed and unwitnessed (including “wake-up”) events.Read More →
The following dates are available for this trial. Trial information last updated on 9 March 2009.
|Start Date||First Received||1st Completion||Completion||Verification||Results|
- Concentric Medical, Inc. Penumbra Inc.
Multicenter randomized controlled trial.